Form 8-K · Current report
T. Rowe Price 8-K, filed Oct 29, 2026
- Filed
- CIK
- 0001113169
- Accession no.
- 0001113169-26-000003
Summary
T. Rowe Price Group reported third-quarter 2026 results, with assets under management of $1.9 trillion, net client outflows of $28.3 billion, and diluted earnings per share of $2.79 ($2.86 adjusted). Chair and CEO Rob Sharps said the firm is expanding its ETF, SMA, and model portfolio businesses and is well positioned to deliver long-term value for clients and stockholders.
Key points
- Ending assets under management were $1.8627 trillion at September 30, 2026, down $30.7 billion during the quarter.
- Q3 2026 net client outflows were $28.3 billion, with equity strategies accounting for $25.6 billion of outflows.
- Net revenues rose 5.9% year over year to $2.0 billion, while the annualized effective fee rate excluding performance-based fees fell to 37.8 basis points from 39.1.
- GAAP diluted EPS was $2.79, down from $2.87 a year earlier, and adjusted diluted EPS was $2.86.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 2.02Results of Operations and Financial Condition
- 9.01Financial Statements and Exhibits
From the filing
Item 2.02. Results of Operations and Financial Condition. On October 29, 2026 we issued an earnings release reporting our results of operations for the three and nine months ended September 30, 2026. A copy of this earnings release is attached hereto as Exhibit 99.1 and is incorporated by reference. The information in this Current Report on Form 8-K and the Exhibit attached hereto shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.